BENEO showcases new sweet excipient at CPhI Worldwide

Ingredients manufacturer BENEO has showcased its new sweet-tasting excipient galenIQ at CPhI Worldwide.

The company’s new excipient is designed for pharmaceutical manufacturers of solid dosage forms who are targeting the growing minitablets trend. 

Although tablets are still the most widely used drug delivery system, many end users, including young children, the elderly and patients with dysphagia, have difficulty swallowing conventional tablets.

Multiparticulate forms such as minitablets are easy to swallow, can be designed to disintegrate rapidly in the buccal cavity or can be sprinkled onto soft food. However, successfully manufacturing minitablets requires the use of a filler-binder with certain characteristics. 

BENEO states gelenIQ offers a range of functionalities that enable high tablet hardness at a low compression force, which is key for the production of minitablets using sensitive multiple-tip punches. 

“Given the special needs of very young and very old patients and the increasing demand for innovative dosage forms, BENEO’s galenIQ is the filler-binder of choice for minitablets. Manufactured from sucrose, it has a sweet taste and enhances the palatability of orodispersible minitablets, ensuring patient compliance,” said Dr Maj-Britt Cepok, head of Business Development Pharma at BENEO.